Financials

  • Market Capitalization 472.38 M
  • Employee 129
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.58
市销率
-6 934.07

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2938
PROK
ProKidney Corp. - Class A Ordinary Shares
1.61 USD-8.52%-21.08%-3.01%-22.60%486.32 M USD
2951
OCGN
Ocugen, Inc. - Common Stock
1.41 USD-4.08%-6.62%+11.02%+25.89%477.32 M USD
2961
VSTM
Verastem, Inc. - Common Stock
5.37 USD-2.89%+19.60%+29.09%+7.83%471.88 M USD
2974
PRTA
Prothena Corporation plc - Ordinary Shares
8.83 USD-4.44%-8.21%+0.68%+37.11%462.28 M USD